Bladder cancer is extremely common in the United States and extremely costly because of the high cost of surveillance. In some patients, office-based surveillance may be a safe, cost-reducing alternative. This article attempts to identify ideal candidates and highlights surveillance strategies that can be employed in an office-based setting.
Keywords: Bladder cancer; Fulguration; Office-based management; Recurrence; Surveillance.
Copyright © 2013 Elsevier Inc. All rights reserved.